November 2, 2015 / 5:08 PM / 3 years ago

BUZZ-Valeant Pharmaceuticals: Surges after Citron has no new allegations


** Drugmaker’s shares surge 8 pct to $101.23 in heavy trading after Citron’s new report has no fresh allegations

** Short-seller Citron Research says is taking a back seat in investigating Valeant, but not backing down from earlier allegations (

** Valeant’s stock had tumbled nearly 36 pct since Oct. 21, when Citron said the Canadian company was using specialty pharmacies to inflate revenue

** Citron's head Andrew Left had said he would update allegations on Valeant on Monday, but told WSJ on Sunday that investors shouldn't "expect anything earth-shattering" in the new report (

** Valeant stock on track for best day since Sept. 30

** Jefferies says Valeant’s decision to cut ties with Philidor, accused of helping it inflate revenue, was the “right move” to regain investor confidence

** Still, Jefferies joined Canaccord Genuity and Goldman Sachs in lowering its price target on stock; Goldman also downgraded stock to “neutral” from “buy”

** Of 22 brokerages, 14 have a “buy” or higher rating, 7 have “hold” rating and 1 says “sell”

** Nearly 12 mln shares traded (vs 25-day moving avg of 17.3 mln), 7th most active NYSE-listed stock

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below